Gene therapy for psychiatric disorders

World J Biol Psychiatry. 2011 Sep;12 Suppl 1(Suppl 1):16-8. doi: 10.3109/15622975.2011.601927.

Abstract

There is no indication that gene therapy can be applied in psychiatric patients any time soon. However, there are several promising developments on the level of experimental neuroscience indicating that gene therapy approaches have an effect in animal models of several psychiatric disorders including drug addiction, affective disorders, psychoses and dementia, modifying behavioural parameters via interventions on the molecular and cellular level. However, before gene therapy in psychiatric disorders can be considered on the human level, not only neurobiological and technical problems need to be overcome, but also important ethical questions answered.

Publication types

  • Review

MeSH terms

  • Affective Disorders, Psychotic / genetics
  • Affective Disorders, Psychotic / physiopathology
  • Affective Disorders, Psychotic / rehabilitation
  • Alzheimer Disease / genetics
  • Alzheimer Disease / physiopathology
  • Alzheimer Disease / rehabilitation
  • Animals
  • Brain / physiopathology
  • Depressive Disorder, Major / genetics
  • Depressive Disorder, Major / physiopathology
  • Depressive Disorder, Major / rehabilitation
  • Disease Models, Animal
  • Gene Expression Regulation / genetics
  • Gene Expression Regulation / physiology
  • Gene Transfer Techniques
  • Genetic Therapy / methods*
  • Humans
  • Mental Disorders / genetics*
  • Mental Disorders / physiopathology
  • Mental Disorders / rehabilitation*
  • Nerve Regeneration / genetics
  • Nerve Regeneration / physiology
  • Neuronal Plasticity / genetics
  • Neuronal Plasticity / physiology
  • Psychotic Disorders / genetics
  • Psychotic Disorders / physiopathology
  • Psychotic Disorders / rehabilitation
  • Substance-Related Disorders / genetics
  • Substance-Related Disorders / physiopathology
  • Substance-Related Disorders / rehabilitation